Computational Structure-Based De Novo Design of Hypothetical Inhibitors Against the Anti- Inflammatory Target COX-2

PLoS ONE - United States
doi 10.1371/journal.pone.0134691
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Synthesis of Novel Naphthalene COX Inhibitors for Anti-Inflammatory Activity

Journal of Applied Pharmaceutical Science
MedicineToxicologyPharmaceuticsPharmacology
2012English

Comparison of Nonsteroidal Anti-Inflammatory Drugs and Cyclooxygenase-2 (COX-2) Inhibitors Use in Australia and Nova Scotia (Canada)

British Journal of Clinical Pharmacology
Pharmacology
2009English

COX-1 and COX-2 Products in the Gut: Therapeutic Impact of COX-2 Inhibitors

Gut
Gastroenterology
2000English

COX-2 Inhibition, Apoptosis, and Chemoprevention by Nonsteroidal Anti-Inflammatory Drugs.

Current Medicinal Chemistry
Organic ChemistryBiochemistryDrug DiscoveryMolecular MedicinePharmacology
2000English

Anti-Inflammatory Function of Arctiin by Inhibiting COX-2 Expression via NF-κB Pathways

Journal of Inflammation
Clinical BiochemistryCell Biology
2011English

Structure-Based Design of Inhibitors of CXCR4.

English

Cox-2 Specific Inhibitors (Coxibs) Crisis

Basrah Journal of Surgery
2003English

Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis

Archives of Internal Medicine
2000English

LigBuilder V3: A Multi-Target De Novo Drug Design Approach

Frontiers in Chemistry
Chemistry
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy